The FDA has issued an urgent recall of losartan potassium tablets from Camber Pharmaceuticals after quality testing detected microscopic glass particles in multiple production lots, posing risks of internal injury.

Affected Products

The recall covers losartan 25mg, 50mg, and 100mg tablets with lot numbers beginning with "LOS26" distributed between January-March 2026. An estimated 2 million bottles are affected.

Patient Advisory

Patients should not stop taking blood pressure medication without doctor guidance but should check lot numbers immediately. Pharmacies are providing replacement medications from alternative manufacturers at no extra cost.